The Canadian Centre for Commercialization of Regenerative Medicine has entered a strategic alliance with its UK and Australian counterparts to drive the commercialization of cell therapies at a global level. The alliance with the Cell Therapy Catapult (UK) and Cooperative Research Centre for Cell Therapy Manufacturing (Australia) is intended to accelerate the dissemination of ideas and technical expertise into the marketplace. Activities will include joint projects, clinical trials, funding, training programs, standardization and regulatory efforts....